Find the Most Effective Treatment for Your Tumor

A Personalized TumorGraft™ from Champions Oncology could improve your outcome and extend your life by predicting which treatment may be more likely to have a positive impact on your cancer1,2. This revolutionary technology uses your own living tumor growing in a mouse to help evaluate treatments.

Champions will then test anticancer drug regimens on the mice to identify which one(s) may be most effective at shrinking your tumor.

Champions has conducted studies that have shown that a treatment that shrinks your tumor that has been implanted into mice has a high likelihood of also working against the tumor in your body1,2.

Your physician will then be able to make treatment decisions for you based on actual observations of how your own tumor sample responded to various anticancer drugs.

The Personalized TumorGraft™ Advantage

  • Testing drug treatments on a Personalized TumorGraft™ may reduce the likelihood of ineffective chemotherapy and possible resulting side effects.
  • Accurate, personalized treatment recommendations could save valuable time and effort by identifying treatment options more likely to result in a positive outcome
  • Testing of novel treatments may guide treating physicians towards treatments they had not previously considered.

References:

  1. Hidalgo M et al. Activity of gemcitabine in direct patient derived xenografts predicts clinical outcome: validation of an in vivo model for drug development. J Clin Oncol 27:15s, 2009 (suppl; abstr 4528)
  2. Hidalgo M et al. A Pilot Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer. Mol Cancer Ther August 2011 10:1311-1316
  3. Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652-4661.
  4. Champions data on file.